filmov
tv
What Causes Blood in Urine? | Cxbladder
Показать описание
Seeing blood in your urine (also known as hematura) can be startling, especially if you don't know the cause. Though many cases of hematuria end up being relatively harmless, you should take this symptom seriously and speak to a doctor as soon as possible. In this video we look at common causes of blood in urine.
If you're experiencing blood in urine and concerned about cancer, ask your doctor about Cxbladder. Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer in hematuria patients and those being monitored for bladder cancer recurrence. The test combines clinical risk factor markers with genetic information, measuring five biomarker genes to detect the presence or absence of bladder cancer.
Cxbladder gives you certainty, resolving diagnostic ambiguity and improving overall detection accuracy. Most patients experiencing hematuria or who are being monitored for bladder cancer recurrence do not have cancer. Cxbladder enables the accurate rule out of patients who do not have bladder cancer, reducing the need for further invasive tests.
With performance proven in 12 peer-reviewed studies, Cxbladder is trusted by over 1,800 US urologists in over 40,000 patients. The test is covered by Medicare and comes with the option of in-home sampling.
In New Zealand, Cxbladder is now accessible to 65% of the population via public healthcare. We offer the test to all other residents via our online shop.
If you're experiencing blood in urine and concerned about cancer, ask your doctor about Cxbladder. Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer in hematuria patients and those being monitored for bladder cancer recurrence. The test combines clinical risk factor markers with genetic information, measuring five biomarker genes to detect the presence or absence of bladder cancer.
Cxbladder gives you certainty, resolving diagnostic ambiguity and improving overall detection accuracy. Most patients experiencing hematuria or who are being monitored for bladder cancer recurrence do not have cancer. Cxbladder enables the accurate rule out of patients who do not have bladder cancer, reducing the need for further invasive tests.
With performance proven in 12 peer-reviewed studies, Cxbladder is trusted by over 1,800 US urologists in over 40,000 patients. The test is covered by Medicare and comes with the option of in-home sampling.
In New Zealand, Cxbladder is now accessible to 65% of the population via public healthcare. We offer the test to all other residents via our online shop.